Navellier & Associates Inc Idexx Laboratories Inc Transaction History

Navellier & Associates Inc

$705 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$391.37 - $557.56 $145,981 - $207,969	373 New	373 $207,000
Q2 2022 Aug 12, 2022	SELL	$327.37 - $553.44 $407,575 - $689,032	-1,245 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$466.52 - $631.01 $8.25 Million - $11.2 Million	-17,688 Reduced 93.42%	1,245 $681,000
Q4 2021 Feb 14, 2022	BUY	$586.54 - $666.48 $1.19 Million - $1.35 Million	2,032 Added 12.02%	18,933 $12.5 Million
Q3 2021 Oct 28, 2021	SELL	$621.9 - $705.76 $4,353 - $4,940	-7 Reduced 0.04%	16,901 $10.5 Million
Q2 2021 Aug 09, 2021	BUY	$486.36 - $637.08 $1,945 - $2,548	4 Added 0.02%	16,908 $10.7 Million
Q1 2021 May 12, 2021	SELL	$465.18 - $551.79 $164,208 - $194,781	-353 Reduced 2.05%	16,904 $8.27 Million
Q4 2020 Feb 05, 2021	BUY	$383.85 - $499.87 $6.33 Million - $8.24 Million	16,480 Added 2120.98%	17,257 $8.63 Million
Q3 2020 Nov 09, 2020	SELL	$334.54 - $406.31 $200,724 - $243,786	-600 Reduced 43.57%	777 $305,000
Q2 2020 Aug 12, 2020	SELL	$230.66 - $330.16 $20,528 - $29,384	-89 Reduced 6.07%	1,377 $455,000
Q1 2020 May 13, 2020	BUY	$182.94 - $290.97 $11,525 - $18,331	63 Added 4.49%	1,466 $355,000
Q4 2019 Feb 12, 2020	SELL	$248.66 - $285.01 $27,103 - $31,066	-109 Reduced 7.21%	1,403 $366,000
Q3 2019 Oct 16, 2019	BUY	$260.07 - $289.93 $3,120 - $3,479	12 Added 0.8%	1,512 $411,000
Q2 2019 Jul 17, 2019	SELL	$215.53 - $275.33 $2.58 Million - $3.3 Million	-11,968 Reduced 88.86%	1,500 $413,000
Q1 2019 May 15, 2019	SELL	$178.02 - $225.69 $166,448 - $211,020	-935 Reduced 6.49%	13,468 $3.01 Million
Q4 2018 Jan 15, 2019	SELL	$176.18 - $248.92 $310,781 - $439,094	-1,764 Reduced 10.91%	14,403 $2.68 Million
Q3 2018 Nov 14, 2018	BUY	$218.82 - $254.46 $28,446 - $33,079	130 Added 0.81%	16,167 $4.04 Million
Q2 2018 Aug 06, 2018	BUY	$185.56 - $227.9 $25,050 - $30,766	135 Added 0.85%	16,037 $3.5 Million
Q1 2018 May 21, 2018	SELL	$157.81 - $204.73 $1.17 Million - $1.52 Million	-7,443 Reduced 31.88%	15,902 $3.04 Million
Q4 2017 Feb 12, 2018	SELL	$147.68 - $168.37 $5.64 Million - $6.43 Million	-38,206 Reduced 62.07%	23,345 $3.65 Million
Q3 2017 Nov 14, 2017	SELL	$150.32 - $166.46 $17,136 - $18,976	-114 Reduced 0.18%	61,551 $9.57 Million
Q2 2017 Aug 24, 2017	BUY	N/A	61,665	61,665 $9.95 Million

Others Institutions Holding IDXX

# of Institutions

1,212

Shares Held

72.5M

Call Options Held

167K

Put Options Held

343K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $34.3B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.

Account